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Abstracts
translocation of the AR to the nuclei, preventing its transcriptional activ-
ity. Among the mechanisms postulated to confer hormone resistance, is
the up-regulation of genes encoding steroidogenic enzymes like
CYP17A1.
Method: We immunohistochemically investigated the expression of
CYP17A1 enzyme in parallel with AR nuclear expression, in a series of
prostate cancer tissue form patients treated with prostatectomy.
Results: CYP17A1 was strongly expressed in the cytoplasm of prostate
cancer cells, ranging from 0% to 100% of cells (median 50%). Thirty cases
out of 53 (56.6%) expressed CYP17A1 in more than 50% of their tumour
cells. The nuclear AR expression in cancer cells ranged from 0-90% among
cases (median 30%). Out of 53 cases, 20 (37.7%) showed expression of the
AR inmore than 50% of cancer cells. A strong significant direct association
between CYP17A and nuclear AR expression was noted (p<0.0001;
r=0.51). This was confirmed in confocal immunofluorescent microscopy,
where the nuclear expression of phosphorylated (active form) of AR was
directly related to cytoplasmic expression of CYP17A1. Analysis of
CYP17A1 expression according to histopathological variables, did not
show any association with T-stage, Gleason score or PSA levels.
Conclusion: CYP17A1 steroidogenic enzyme is strongly expressed in
half about of human prostate carcinomas, implying an intracellular an-
drogen synthesis by cancer cells. CYP17A1 expression could have a
value as a biomarker for the treatment of hormone refractory disease with
specific CYP17A inhibitors.
E-PS-08-030
A rare case of cystic hemangioma of the adrenal gland
D. Anestakis*, G. Hahalis, C. Nikolaidou, M.-E. Givannakis, N. Raikos,
C. Tsompanidou
*Aristotle University Thessaloniki, Necrotomic Histopathology, Greece
Background & Objective: Cavernous hemangiomas of the adrenal gland
are rare. Since the first cavernous hemangioma of the adrenal gland was
surgically removed in 1955, only 64 cases have appeared in the medical
literature. While there are certain features suggestive of the diagnosis, they
fall short of being diagnostic. This lack of specificity in pre-operative stud-
ies often prevents a conclusive exclusion of malignancy from the differen-
tial diagnosis. We report the morphologic and immunohistochemical fea-
tures of a case of cystic hemangioma that occurred in a woman.
Method: A 19-year-old female presented to our hospital with a short
history of abdominal pain. CTshowed a well-defined lesion in the middle
of the right adrenal gland andMRI images are showed amulti-cystic mass
on the right adrenal gland. The patient underwent open right
adrenalectomy.
Results:Macroscopically the lesion consisted of a well-circumscribed
mass measuring 8x6x4 cm. with small and large cysts filled with se-
rous and hemorrhagic fluid. Microscopically the cysts filled with
blood and lined by flat endothelial cells with no atypia and no mitosis.
These cells were positive with CD34. Among these cysts there was
tissue of normal adrenal gland and foci of fibrous tissue with calcifi-
cations. There was no evidence of malignancy. According to these
histological features this mass was diagnosed as cystic hemangioma
of the adrenal gland.
Conclusion:We conclude that preoperative recognition of cystic heman-
gioma which has an excellent outcome might help surgeons approach the
patient conservatively.
E-PS-08-032
Gastrointestinal metastasis of primary thyroideal eptihelioid
angiosarcoma with CYP2D6 c.506-1G>A polymorphism: molecular
and immunophenotypical characterisation
E. Sanfeliu*, A. Martinez, A. Diez-Caballero, A. Flor, I. Ramos, J.
Capdevila, C. Llebaria
*Centro Medico Teknon, Pathology, Barcelona, Spain
Background & Objective: Thyroid epithelioid angiosarcoma is a rare
highly aggressive malignant vascular tumour, mainly seen in the Alpine
region and few cases are described in non-Alpine patients. The
t(1;3)(p36.3;q25) translocation is present some cases studied, leading to
CAMTA1 expression by IHC. Further molecular characterization has yet
to be done.
Method:A 62 years old non-Alpine white patient, with ulcerative colitis
and underwent left hemi-thyroidectomy for a benign pathology (by clin-
ical records). Subsequent two biopsies one year and fourth month after
render a diagnosis of undifferentiated carcinoma in left laterocervical
region. The patient consulted by gastrointestinal bleeding and endoscopic
biopsies revealed metastasis of undifferentiated carcinoma. An intestinal
resection was made. We review clinical, histological and molecular stud-
ies from OncoDEEP™.
Results: The histologic study showed arrangements of polygonal cells
with prominent nucleoli and atypical mitosis in cleft-like spaces. Tumour
cells were positive for endothelial markers such as CD31 and Factor VIII
and expressed CAMTA1. The review of previous biopsies, including
thyroidectomy specimen, showed similar features. The patient progressed
with locoregional disease and bone metastasis and died after eighteen
months from first surgery. The molecular study demonstrated a polymor-
phism CYP2D6*4 c.506-1G>A variant, which is found in pituitary and
papillary thyroid tumours.
Conclusion: We present an atypical non-Alpine presentation of this rare
neoplasm presenting with bleeding from intestinal metastasis leading to
the diagnosis of a primary tumour located in the thyroid gland. The
presence of a CYP2D6*4 is associated with cancer risk and may be
related with the peculiar geographic distribution of this rare form of neo-
plasm.
E-PS-09-001
Peculiar features of CEACAM1 and E-cadherin expression in the
uterus
M. Lyndin*, A. Romaniuk, V. Sikora, N. Gyryavenko, O. Kravtsova, V.
Panchenko, Y. Lyndina, B. B. Singer
*Sumy State University, Pathology, Ukraine
Background & Objective: The aim of our study was to characterize the
expression pattern of сarcinoembryonic antigen related cell adhesion
molecule 1 (CEACAM1) and E-cadherin in normal, hyperplastic and
tumour tissues of the uterine, and to determine the potential correlation
between these two adhesion molecules.
Method: 45 samples of the uterine tissue (normal, hyperplastic and tu-
mour tissues) were selected for the study. The presence of CEACAM1
(С5-1Х8–0.1μg/ml) and E-cadherin (EP700Y–0.5μg/ml) receptors was
detected by the immunofluorescence analyses.
Results: E-cadherin is expressed on the basal surface and in the intercellu-
lar contacts by all cells of the normal endometrium and under the hyper-
plasia. The endometrial adenocarcinoma tissues showed a variable E-
cadherin expression: basal-intercellular – under formation the glands by
the neoplastic cells, entire membranous – under the solid growth of cancer
cells and the decreasing expression – when the malignant progression is
developing. Conversely, the CEACAM1 receptors are present on the apical
surface of the normal and pre-tumour tissues of the uterus. They appear in
the cytoplasmwhen the anaplasia level of the neoplastic cells is increased. It
was determined that E-cadherin-positive cells are present when there is no
CEACAM1 receptor expression.
Conclusion: The endometrial tissue shows a variable expression of
СЕАCAM1 and E-cadherin receptors depending on the pathological
changes in the uterus. Different patterns of these proteins indicate the
absence of any functional correlation between them. However, the
alterations of both protein location from cell membrane to their
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disappearence or translocation into cytoplasm seems to represent nov-
el markers for the appearance and development of the neoplastic pro-
cess.
E-PS-09-002
The aggressive EpCAM+CD45+ phenotype in serous epithelial ovar-
ian cancer
V. Maffeis*, L. Nicolè, A. Grego, C. M. Radu, P. Simioni, A. Fassina
*University of Padova, Dept. of Medicine, Italy
Background & Objective: Epithelial ovarian cancer (EOC) is the lead-
ing cause of death for gynaecological malignancies, especially in western
countries. Recently, Akther and colleagues identified a haemato (CD45) -
epithelial (EpCAM) phenotype of serous EOC with aggressive features,
both in ascitic fluid and primary tumours. This phenotype is drug-
resistant (versus EpCAM+ neoplastic cells), highly invasive (mesenchy-
mal gene expression) and consists of subpopulations of ovarian cancer
stem cells (CD133+ and CD117+CD44+) with MCH I over-expression
(ability to evasion of immune surveillance). These features suggest a
possible role for EpCAM+CD45+ phenotype in development of perito-
neal carcinomatosis and multi-drug resistance. Aim of the present study
was to investigate EpCAM+CD45+ phenotype in EOC tissue samples of
primary tumour, in ascitic fluid and, for the first time, extraovarian
implants.
Method: EpCAM+CD45+ phenotype was assessed by immunohisto-
chemistry (serial sections of FFPE samples were digitalized and then
aligned to assess the co-localization) and confirmed by immunofluores-
cence in 5 cases of serous EOC. These results will be integrated and
stratified using clinical and follow-up data (available for all 60 patients
enrolled). Immunohistochemistry in the large series is in progress.
Results: EpCAM+CD45+ phenotype was found in extra-ovarian im-
plants in all (5/5) investigated cases and in 60% (3/5) of primary tumours.
Interestingly, the two discordant cases showed EpCAM+CD45+ pheno-
type only after chemotherapy (in all cases the positivity consisted of
isolated small groups of cells).
Conclusion: Our preliminary findings showed that EpCAM+CD45+
phenotype was present in extra-ovarian implants of EOC, further
supporting the role of this neoplastic phenotype in EOC carcinomatosis.
The results will be confirmed on the complete cohort.
E-PS-09-003
Glandular carcinomas of the endocervix: a clinicopathological re-
view – experience of a tertiary referral centre
R. Amorim*, C. Estima Fleming, M. Marques Oliveira, L. Ferreira, N. J.
Lamas, J. R. Brandão, B. Fernandes, F. Moreno, A. Duarte, J. R. Vizcaíno
*Centro Hospitalar do Porto, Serviço de Anatomia Patológica, Portugal
Background & Objective: We aimed to report the experience of
endocervical adenocarcinoma diagnosis in a tertiary gynaecological re-
ferral centre.
Method: All endocervical adenocarcinomas diagnosed over a ten-year
period (2008-2018) were reviewed. Histopathological features, associa-
tion with Human Papilloma Virus (HPV) infection and clinical data were
evaluated.
Results: Of the 23 cases retrieved, 10 were classified as adenocarci-
noma NOS, 5 as endocervical adenocarcinoma, usual type, 3 as
endometrioid carcinoma, 3 as villoglandular carcinomas, 1 as mucin-
ous carcinoma, gastric type and 1 as adenocarcinoma in situ. The mean
age at diagnosis was 48 years (30-80). HPV genotyping was per-
formed in 4 cases, all positive for high-risk HPV genotypes
(hrHPV). The majority of the cases (21, [91.3%]) represented invasive
disease (stage I to III – most of them were stage I), whereas 1 (4.35%)
was in situ and 1 (4.35%) had unknown stage. Only one patient died
due to adenocarcinoma.
Conclusion: Our results do not parallel the classification reported in the
literature, where endometrioid carcinomas are rare and account for no
more than 5% of all endocervical adenocarcinomas. In our department,
they account for nearly 13%. This difference might be associated with
patient selection bias, population based susceptibility and a small sample
size. In terms of HPVinfection, all the adenocarcinomas tested for hrHPV
had positive results. Most of our cases were detected in an early stage
which was associated with a high survival rate.
E-PS-09-004
Uterine florid cystic endosalpingiosis
R. Machado-Neves*, J. dos Santos, T. Amaro, M. Honavar
*ULSMatosinhos, Pathology, Matosinhos, Portugal
Background&Objective: Endosalpingiosis is a rare benign entity, char-
acterized by tubal epithelium outside the fallopian tube. It has been de-
scribed since 1930 in multiple organs. Florid cystic endosalpingiosis
(FCE) is a rare presentation in the uterus. We report a case of uterine FCE.
Method: Clinical history, radiological exams, macroscopic and histolog-
ical features have been reviewed.
Results: 56-year-old woman with metrorrhagia and endometrial thicken-
ing, was submitted to three hysteroscopies and resections of endometrial
polyps of over a period of 15 months. Abdominal CT scan showed a 33
mm endometrial polyp and a tubular, serpiginous structure of 60 x 28mm
adjacent exteding into the myometrium, suggestive of a haematosalpinx.
She underwent a total hysterectomy: the uterus (101 g) was enlarged with
a thin-walled collapsed cyst on the serosal surface of the fundus which
communicated with a solid and cystic mass measuring 75 x 50 x 40 mm,
traversing the full thickness of the myometrium to present as a polyp
within the endometrial cavity. Ovaries contained benign serous cysts
and fallopian tubes were normal. Microscopically there were cystic
spaces of varying sizes lined by simple cuboidal and ciliated tube-type
epithelium. No cytologic atypia was seen. The stroma between the glands
and cysts was fibromuscular, with no evidence of endometrial stroma.
Conclusion: ECF of the uterus is a rare disease of unknown etiology,
with indication for conservative treatment. The differential diagnosis in-
cludes benign entities (including mullerianosis, adenomyosis, florid me-
sonephric hyperplasia) and adenocarcinoma.
E-PS-09-005
Ovarian masses in children and adolescents: a case series
N. Redissi*, R. Jouini, F. Khanchel, W. Koubaa, R. Benabdallah, A.
Chadli Debbich, E. Benbrahim
*Hopital Militaire Tunis, Pathology, Tunisia
Background & Objective: Ovarian masses in children and adolescents
are unique due to their rarity and controversial management. Their inci-
dence is estimated at 2.6 cases per 100,000 girls per year, and malignant
ovarian tumours account for 0.9% of all childhood and adolescent malig-
nancies. Although benignmasses are more common than malignant ones,
it is imperative to diagnose malignancy at an early stage by various
multimodal diagnostic methods. The purpose of this study is to report a
series of ovarian masses in children and adolescents and to describe
clinicopathological aspects of these lesions.
Method: All ovarian masses in children and adolescents resected or
biopsied in Habib Thameur Hospital from 2001 to 2018 were reviewed
retrospectively. Patient’s age, pathological data and outcome were obtain-
ed from medical records.
Results: Results 29 cases of ovarian masses were found: 7 mature tera-
tomas, 4 serous cystadenomas, one mucinous cystadenoma, 5 serous
cystadenofibromas, one endometriotic cyst, 7 follicular cysts, 2 cases of
dysgerminoma, one case of gonadoblastoma, one case of juvenile granu-
losa cell tumour and one unclassified tumour. The age of patients was
varying between 19 days and 16 years. The distribution of ovarian masses
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